Comorbidities and systemic steroids drive pneumonia risk in inflammatory bowel disease: Propensity score-matched cohort study

doi:10.4292/wjgpt.v16.i2.105335

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 16, Issue 2

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Supplementary Materials of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (215)

All Articles published online

The chart showing PDF series, HTML series, Figures (1-5) series, Tables (1-3) series.

Item

Count

PDF

HTML

100

Figures (1-5)

Tables (1-3)

Sum=156

Featured Article

The chart showing Browse series, Download series.

Item

Count

Browse

Download

Sum=24

Publishing Process of This Article

Item

Count

Browse

Download

Sum=29

Jun 5, 2025 (publication date) through Jun 6, 2025

Times Cited of This Article

Times Cited (0)

Journal Information of This Article

Publication Name

World Journal of Gastrointestinal Pharmacology and Therapeutics

ISSN

2150-5349

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Retrospective Cohort Study

World J Gastrointest Pharmacol Ther. Jun 5, 2025; 16(2): 105335
Published online Jun 5, 2025. doi: 10.4292/wjgpt.v16.i2.105335

Full Size Figure Download Figure

Figure 1 Flowchart of study population selection and propensity score matching process. IBD: Inflammatory bowel disease; PS: Propensity score.

Citation: Eun Y, Culpepper-Morgan J, Akanmode AM, Thu MB, Sta Lucia AA, Thearle MS, Trousdale RK. Comorbidities and systemic steroids drive pneumonia risk in inflammatory bowel disease: Propensity score-matched cohort study. World J Gastrointest Pharmacol Ther 2025; 16(2): 105335
URL: https://www.wjgnet.com/2150-5349/full/v16/i2/105335.htm
DOI: https://dx.doi.org/10.4292/wjgpt.v16.i2.105335